3655 36 St NW
Calgary AB T2L 1Y8


Dr. Joseph Tucker

President & CEO

Dr. Jillian Hagel

Chief Technology Officer

Dr. Peter Facchini

Chief Scientific Officer

Terry Zimaro, CPA, CA

Chief Financial Officer

MagicMed Industries Inc.

MagicMed’s mission is to unlock the full potential ofpsychedelic-derived medicines for the treatment of neurological and psychological indications.

MagicMed Industries Inc. is a biotechnology focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed’s molecular derivatives library, the Psybrary™, is intended to be an essential building block from which industry partners can develop new patented products.